Mary Stuart
About
In The Last Decade
Mary Stuart
22 papers receiving 792 citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Pulmonary and Respiratory Medicine 415
- Oncology 415
- Cancer Research 196
- Nutrition and Dietetics 122
- Genetics 108
Countries citing papers authored by Mary Stuart
This map shows the geographic impact of Mary Stuart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Stuart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Stuart more than expected).
Fields of papers citing papers by Mary Stuart
This network shows the impact of papers produced by Mary Stuart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Stuart. The network helps show where Mary Stuart may publish in the future.
Co-authorship network of co-authors of Mary Stuart
This figure shows the co-authorship network connecting the top 25 collaborators of Mary Stuart. A scholar is included among the top collaborators of Mary Stuart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Stuart. Mary Stuart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial breakdown → | 384 |
| 5 | 34 | |
| 6 | 2 | |
| 7 | 7 | |
| 8 | 17 | |
| 9 | 1 | |
| 10 | Effects of the Src inhibitor saracatinib (AZD0530) on renal function in healthy subjects. | 4 |
| 11 | 5 | |
| 12 | 28 | |
| 13 | 41 | |
| 14 | 62 | |
| 15 | 6 | |
| 16 | 34 | |
| 17 | 31 | |
| 18 | Zinc deficiency and eating disorders. | 32 |
| 19 | 30 | |
| 20 | 9 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.